We are live on ! Find out more
PAM

Panagora Asset Management Portfolio holdings

AUM $32.6B
1-Year Est. Return 52.29%
This Fund
S&P 500
This Quarter Est. Return
+15.1%
1 Year Est. Return
+52.29%
3 Year Est. Return
+171.1%
5 Year Est. Return
+242.78%
10 Year Est. Return
+962.16%
AUM
$22.5B
AUM Growth
+$1.01B
Cap. Flow
-$1.78B
Cap. Flow %
-7.91%
Top 10 Hldgs %
17.81%
Holding
2,706
New
231
Increased
769
Reduced
968
Closed
182

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$136M
2
INCY icon
Incyte
INCY
+$93.7M
3
SHW icon
Sherwin-Williams
SHW
+$78.1M
4
PH icon
Parker-Hannifin
PH
+$77.1M
5
MDT icon
Medtronic
MDT
+$70.7M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$145M
2
AMGN icon
Amgen
AMGN
+$136M
3
PLD icon
Prologis
PLD
+$128M
4
ADBE icon
Adobe
ADBE
+$121M
5
HUM icon
Humana
HUM
+$116M

Sector Composition

Rank Sector Weight
1 Technology 18.07%
2 Financials 16.28%
3 Healthcare 12.58%
4 Consumer Discretionary 11.23%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSET icon
2476
Bassett Furniture
BSET
$176M
-46,691
Closed -$936K
STEX
2477
Streamex Corp
STEX
$75.3M
-1,432
Closed -$61K
CDNA icon
2478
CareDx
CDNA
$2.32B
-76
Closed -$2K
CECO icon
2479
Ceco Environmental
CECO
$4.01B
-5,379
Closed -$36K
CEVA icon
2480
CEVA Inc
CEVA
$992M
-15,161
Closed -$335K
CKPT
2481
DELISTED
Checkpoint Therapeutics
CKPT
-903
Closed -$16K
CLVT icon
2482
Clarivate
CLVT
$1.18B
-147,210
Closed -$1.41M
CNTY icon
2483
Century Casinos
CNTY
$33.5M
-12,189
Closed -$90K
CPK icon
2484
Chesapeake Utilities
CPK
$3.2B
-1,664
Closed -$135K
CRNT icon
2485
Ceragon Networks
CRNT
$202M
-33,767
Closed -$128K
BGMS
2486
Bio Green Med Solution Inc
BGMS
$5.35M
0
-$16K
CYTK icon
2487
Cytokinetics
CYTK
$11B
$0 ﹤0.01%
13
DARE icon
2488
Dare Bioscience
DARE
$19.9M
-1,626
Closed -$14K
EDUC icon
2489
Educational Development Corp
EDUC
$11.8M
-51
Closed
EFSC icon
2490
Enterprise Financial Services Corp
EFSC
$2.4B
-12,636
Closed -$475K
EMB icon
2491
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
-29,892
Closed -$3.11M
EQBK icon
2492
Equity Bancshares
EQBK
$1.05B
-26,421
Closed -$931K
EYE icon
2493
National Vision
EYE
$1.8B
-82,683
Closed -$2.33M
GES
2494
DELISTED
Guess Inc
GES
-83,905
Closed -$1.74M
GNK icon
2495
Genco Shipping & Trading
GNK
$1.1B
-49,174
Closed -$388K
GNSS icon
2496
Genasys
GNSS
$80.2M
-10,266
Closed -$26K
GPRO icon
2497
GoPro
GPRO
$126M
-97,659
Closed -$414K
GYRE icon
2498
Gyre Therapeutics
GYRE
$714M
$0 ﹤0.01%
8
-3
-27% -$193
HBNC icon
2499
Horizon Bancorp
HBNC
$1.05B
-959
Closed -$15K
INTT icon
2500
inTEST
INTT
$180M
-8,919
Closed -$55K

Similar funds

Panagora Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Panagora Asset Management held 2,706 positions worth $22.5B, up 4.7% from $21.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Panagora Asset Management withdrew a net $1.78B in Q1 2019, closing 182 positions and reducing 968 holdings. Its most notable exit was Athenahealth, Inc., an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Panagora Asset Management opened a new position in iShares MSCI Hong Kong ETF worth $46.3M.

  • Panagora Asset Management's largest Q1 2019 buy was iShares MSCI Hong Kong ETF: 1,767,867 shares worth $46.3M.
  • Panagora Asset Management added most to Thermo Fisher Scientific in Q1 2019, an estimated $136M increase.
  • Panagora Asset Management's biggest Q1 2019 reduction was UnitedHealth, cutting an estimated $145M.
  • Panagora Asset Management fully exited Athenahealth, Inc. in Q1 2019, selling an estimated $19.8M.
  • Panagora Asset Management's ten largest holdings make up 18% of its $22.5B portfolio in Q1 2019.
  • Panagora Asset Management opened 231 new positions and closed 182 in Q1 2019.
  • Panagora Asset Management's portfolio value rose 4.7% quarter-over-quarter to $22.5B.

Based on Panagora Asset Management's 13F filing for Q1 2019, filed 15 May 2019.